IP Library Granted Patent US 8,900,180
Granted Patent B2
US 8,900,180 · App. 12/092,733 · Granted Dec 2, 2014

Coatable compositions, coatings derived therefrom and microarrays having such coatings

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,900,180
App. No.
12/092,733
Granted
Dec 2, 2014
Kind
B2
Abstract

Coatable compositions and coatings derived from the coatable compositions, and microarrays comprising such coatings are described. In one aspect, the invention provides a microarray comprising: a plurality of microneedles extending from a support substrate; a coating deposited on at least one of the plurality of microneedles, the coating comprising an active agent and a biological salt. In another aspect, the invention provides a coatable composition, comprising: active agent; a biological salt; and solvent. In still another aspect, the invention provides a dried coating coated on a microneedle, the coating comprising: an active agent; and a biological salt.

Claims (10)

1. A microarray comprising:

a plurality of microneedles extending from a support substrate; and

a coating deposited on at least one of the plurality of microneedles, the coating comprising an active agent and a biological salt, wherein the coating is obtainable from a coatable composition comprising 100 parts by weight of at least one active agent and at least 50 parts by weight of at least one biological salt.

2. A microarray according to claim 1 wherein the height of the microneedles is between about 1 μm and about 400 μm.

3. A microarray according to claim 1 wherein the microneedles each have an aspect ratio of at least about 2:1.

4. A microarray according to claim 1 wherein the microneedles each have an aspect ratio of at least about 3:1.

5. A microarray according to claim 1 wherein the microneedles each have an aspect ratio of at least about 5:1.

6. A microarray according to claim 1 wherein the microarray comprises up to 1000 microneedles extending from a support substrate.

7. A microarray according to claim 1 wherein each microneedle comprises a base portion attached to the support substrate and a tip portion distal from the support substrate, the coating being on the tip portion of at least one of the plurality of microneedles.

8. A microarray according to claim 1 wherein the biological salt is selected from monosodium citrate, disodium citrate, trisodium citrate, monopotassium citrate, dipotassium citrate, tripotassium citrate, and combinations of two or more of the foregoing.

Assignments (5)
SECURITY INTEREST Recorded Dec 14, 2022
From: KINDEVA DRUG DELIVERY L.P.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 062122/0618 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED AT R/F 053586/0715 Recorded Dec 12, 2022
From: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
To: KINDEVA DRUG DELIVERY L.P.
Reel/Frame 062115/0707 →
SECURITY INTEREST Recorded Aug 24, 2020
From: KINDEVA DRUG DELIVERY L.P.
To: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
Reel/Frame 053586/0715 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2020
From: 3M COMPANY; 3M INNOVATIVE PROPERTIES COMPANY
To: KINDEVA DRUG DELIVERY L.P.
Reel/Frame 052818/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2008
From: WOLTER, JAMES T.; SIMONS, JOHN K.; JOHNSON, PETER R.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 020907/0419 →